Lv31
348 积分 2024-04-10 加入
AB0382 IDENTIFYING MEANINGFUL ASPECTS OF WORST ITCH IN CUTANEOUS LUPUS ERYTHEMATOSUS FOR ASSESSMENT USING AN ITCH NUMERIC RATING SCALE
5小时前
求助中
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
5个月前
已完结
Dupilumab-associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia-specific IgE: a multicentre, prospective cohort study
5个月前
已完结
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
5个月前
已完结
Dupilumab-associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia-specific IgE: a multicentre, prospective cohort study
5个月前
已完结
Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patients
6个月前
已完结
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
6个月前
已完结
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
6个月前
已完结
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
6个月前
已完结
皖公网安备34019202002308
